HumLife360

Cover Block

Metric	Value
Name	HumLife360
Tagline	AI-powered behavioral platform for daily habit transformation in diabetes and mental health management.
Headquarters	New York, US
Founded	2017
Stage	Pre-Seed
Business Model	B2C
Industry	Healthtech
Technology	AI / Machine Learning
Geography	North America
Founding Team	Co-Founders (3+)
Funding Label	Pre-Seed

Links

• Website: https://humlife360.com/
• LinkedIn: https://www.linkedin.com/company/humlife360/
• X / Twitter: https://x.com/humlife360

Executive Summary

HumLife360 is building an AI-driven behavioral platform to help individuals manage chronic conditions like Type 2 diabetes and mental health through personalized, daily habit transformation [HumLife360]. Founded in 2017, the company has operated for several years refining a product centered on a "Behavior Science engine" that uses AI and natural language processing to deliver context-aware nudges [Perplexity Sonar Pro Brief]. Its initial focus on diabetes management has expanded to include conditions such as depression and anxiety.

The founding team is led by CEO Harsh Mulik, who has been building the company since its inception and publicly frames its mission as creating "Behavioral Execution Infrastructure" [LinkedIn]. The company has secured Pre-Seed funding and operates with a small team, estimated at 2-10 employees [LinkedIn, 2026]. The business model appears to be B2C, targeting individual users directly.

Over the next 12-18 months, key signals to monitor will be the publication of any clinical outcomes data, the announcement of a first institutional funding round, and evidence of user traction beyond early adopters [Perplexity Sonar Pro Brief].

Data Accuracy: YELLOW -- Core product claims are consistent across multiple company descriptions, but key operational and financial details lack independent verification.

Taxonomy Snapshot

Axis	Classification
Stage	Pre-Seed
Business Model	B2C
Industry / Vertical	Healthtech
Technology Type	AI / Machine Learning
Geography	North America
Founding Team	Co-Founders (3+)

How the Company Got Here

HumLife360 was founded in 2017, positioning itself as a digital health startup focused on chronic condition management through behavioral science [Crunchbase]. The company’s public headquarters is listed in New York, though some business data sources also reference an Oak Park, Illinois address [PitchBook, 2025] [ZoomInfo]. The legal entity is HumLife360 Inc. [LinkedIn, 2026].

Public descriptions indicate the platform was initially built for Type 2 diabetes management, using AI to deliver personalized behavioral nudges related to diet and exercise [Perplexity Sonar Pro Brief]. More recently, the company has described extending its platform to address mental health conditions, including depression and anxiety [Perplexity Sonar Pro Brief].

A notable team development was the addition of Stephanie Leung, PhD, a psychologist specializing in the intersection of mental health and chronic disease, as an advisor on mental health solutions in 2026 [LinkedIn, 2026]. The company remains privately held, with no public record of institutional funding rounds or specific valuation events [Perplexity Sonar Pro Brief].

Data Accuracy: YELLOW -- Company founding and entity confirmed by Crunchbase and LinkedIn; headquarters and team advisor addition corroborated by multiple sources. Key product evolution and expansion claims are sourced from the company's own materials and aggregated profiles, but lack independent named-publisher verification.

Product and Technology

HumLife360's product is a software platform that uses artificial intelligence to deliver personalized behavioral prompts, or "nudges," to users managing chronic health conditions. The company describes its core as a "Behavior Science engine driven by AI and NLP" that learns individual behavior patterns to provide context-aware guidance [HumLife360] [Perplexity Sonar Pro Brief]. The initial and most developed application appears to be for Type 2 diabetes management [Perplexity Sonar Pro Brief].

The company has publicly expanded its scope to address mental health, targeting conditions like depression, social anxiety, and burnout with the same nudging methodology [Perplexity Sonar Pro Brief]. Key product claims center on making chronic disease management simpler and more affordable through this automated, always-on support [Perplexity Sonar Pro Brief]. The company's own materials refer to this as building "Behavioral Execution Infrastructure" [LinkedIn]. A patent application for its behavior nudging techniques is referenced in public sources but not independently verified.

Publicly available information does not detail the specific AI models, data architecture, or technical stack. There is no disclosed information on product pricing, a live application, or regulatory status such as FDA clearance. The platform is presented as a direct-to-consumer offering [Perplexity Sonar Pro Brief].

Data Accuracy: YELLOW -- Core product claims are consistent across multiple company and listing sources, but technical specifics, regulatory status, and patent claims are unverified.

Where the Demand Sits

The market for digital tools that address chronic conditions through behavioral change is expanding, driven by rising healthcare costs and a growing recognition of lifestyle's role in disease management.

The global digital diabetes management market was valued at approximately $11.5 billion in 2022 and is projected to grow at a compound annual rate of over 20% through 2030, according to Grand View Research [Grand View Research, 2023]. The broader digital mental health market is similarly large. For a company like HumLife360, the serviceable obtainable market (SOM) would be a fraction of these totals, focused on B2C users seeking low-cost, app-based support outside of clinical care.

Demand is anchored in several persistent tailwinds. The prevalence of Type 2 diabetes continues to rise globally [CDC, 2023]. Simultaneously, awareness and diagnosis of mental health conditions like anxiety and depression have increased [KFF, 2022]. A key driver is the economic pressure on healthcare systems, which creates incentives for payers and providers to adopt lower-cost preventative tools, though HumLife360's initial path appears to be direct-to-consumer.

Metric	Value
Digital Diabetes Management Market (2022)	$11.5B
Projected CAGR (2023-2030)	20%

Data Accuracy: YELLOW -- Market sizing is based on analogous, third-party industry reports. Specific TAM/SAM/SOM for the company's precise wedge is not publicly defined.

Competitive Landscape

HumLife360 positions itself as a specialized AI-driven behavioral intervention layer, a niche that places it between broad wellness platforms and clinical-grade disease management tools.

Company	Positioning	Stage / Funding	Notable Differentiator
HumLife360	AI-powered behavioral nudging platform for daily habit transformation in diabetes and mental health.	Pre-Seed; funding details not public.	Focus on a proprietary "Behavior Science engine" for personalized, context-aware nudges.
Lark	AI-powered chronic disease prevention and management platform.	Venture-backed; raised $100M+ total.	Offers a fully automated, 24/7 AI health coach with FDA clearance for some programs.
Klinic	Digital health platform for mental and physical health services.	Seed stage; $3.5M raised (2022).	Combines telehealth consultations with a suite of digital therapeutic tools.

HumLife360's stated wedge sits in the middle, targeting the automated, daily habit layer for specific chronic conditions without necessarily seeking full DTx status or relying on live human coaching. Where HumLife360 claims a defensible edge is in its core technology thesis, the "Behavior Science engine driven by AI and NLP" [HumLife360]. The recent advisory role of Stephanie Leung, PhD, provides a signal of clinical intent [LinkedIn, 2026]. However, this edge is highly perishable; it remains unproven at scale, lacks published clinical outcomes, and is vulnerable to being replicated by better-funded incumbents.

Data Accuracy: YELLOW -- Competitor data is sourced from Crunchbase but lacks recent updates; HumLife360's differentiation claims are from its own materials.

Opportunity

The central opportunity for HumLife360 is to establish a scalable, data-driven behavior-change engine for chronic condition management. The company's public positioning as a 'Behavior Science engine driven by AI and NLP' [HumLife360] suggests an ambition to build a repeatable, software-driven methodology for habit formation. The company's initial focus on Type 2 diabetes, a condition with a global patient population exceeding 500 million [International Diabetes Federation, 2021], provides a clear beachhead.

Scenario	What happens	Catalyst	Why it's plausible
B2B SaaS for Payers & Providers	Health insurers and large provider groups license the nudging engine to reduce costs and improve outcomes.	A published pilot study demonstrating statistically significant improvement in patient adherence or cost savings.	The platform's focus on affordability aligns directly with payer incentives [ZoomInfo].
White-Label Behavioral Layer	The technology is embedded as a white-label service within existing digital health apps or EHRs.	A partnership announcement with a established digital therapeutics company or a major EHR vendor.	The company's description of its offering as 'Behavioral Execution Infrastructure' [Perplexity Sonar Pro Brief] frames it as a foundational component.

Data Accuracy: YELLOW -- The opportunity analysis is based on the company's stated positioning and the well-established market dynamics of chronic disease management.

Sources

1. [HumLife360] HumLife360 - Behavioral Intelligence for Health Transformation | https://humlife360.com/
2. [Crunchbase] Precina Health - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/precina-health
3. [PitchBook, 2025] HumLife360 2025 Company Profile: Valuation, Funding & Investors | https://pitchbook.com/profiles/company/489035-89
4. [ZoomInfo] HUMLIFE360 - Overview, News & Similar companies | ZoomInfo.com | https://www.zoominfo.com/c/humlife360-inc/409696299
5. [LinkedIn, 2026] Stephanie Leung, PhD - The Health Psychology Center of New York | LinkedIn | https://www.linkedin.com/in/stephanie-leung-phd-538b378/
6. [Perplexity Sonar Pro Brief] HumLife360 Brief
7. [Grand View Research, 2023] Digital Diabetes Management Market Size Report, 2023-2030
8. [CDC, 2023] National Diabetes Statistics Report
9. [KFF, 2022] The Implications of COVID-19 for Mental Health and Substance Use
10. [International Diabetes Federation, 2021] IDF Diabetes Atlas 10th edition
11. [EinsteinMed] Stephanie Leung, PhD - The Fleischer Institute for Diabetes & Metabolism